GLUE
Price
$4.60
Change
-$0.06 (-1.29%)
Updated
Jun 27 closing price
Capitalization
282.95M
38 days until earnings call
IMNM
Price
$8.77
Change
-$0.02 (-0.23%)
Updated
Jun 27 closing price
Capitalization
763.1M
44 days until earnings call
Interact to see
Advertisement

GLUE vs IMNM

Header iconGLUE vs IMNM Comparison
Open Charts GLUE vs IMNMBanner chart's image
Monte Rosa Therapeutics
Price$4.60
Change-$0.06 (-1.29%)
Volume$942.63K
Capitalization282.95M
Immunome
Price$8.77
Change-$0.02 (-0.23%)
Volume$1.07M
Capitalization763.1M
GLUE vs IMNM Comparison Chart in %
Loading...
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLUE vs. IMNM commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Buy and IMNM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GLUE: $4.60 vs. IMNM: $8.77)
Brand notoriety: GLUE and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 213% vs. IMNM: 120%
Market capitalization -- GLUE: $282.95M vs. IMNM: $763.1M
GLUE [@Biotechnology] is valued at $282.95M. IMNM’s [@Biotechnology] market capitalization is $763.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLUE and IMNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 3 bullish TA indicator(s).

  • GLUE’s TA Score: 4 bullish, 5 bearish.
  • IMNM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both GLUE and IMNM are a bad buy in the short-term.

Price Growth

GLUE (@Biotechnology) experienced а -0.65% price change this week, while IMNM (@Biotechnology) price change was +0.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

GLUE is expected to report earnings on Aug 07, 2025.

IMNM is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($763M) has a higher market cap than GLUE($283M). IMNM YTD gains are higher at: -17.420 vs. GLUE (-33.718). GLUE has higher annual earnings (EBITDA): 6.14M vs. IMNM (-175.18M). GLUE (326M) and IMNM (317M) have equal amount of cash in the bank . IMNM has less debt than GLUE: IMNM (4.77M) vs GLUE (41.9M). GLUE has higher revenues than IMNM: GLUE (159M) vs IMNM (10.9M).
GLUEIMNMGLUE / IMNM
Capitalization283M763M37%
EBITDA6.14M-175.18M-4%
Gain YTD-33.718-17.420194%
P/E Ratio38.25N/A-
Revenue159M10.9M1,459%
Total Cash326M317M103%
Total Debt41.9M4.77M878%
TECHNICAL ANALYSIS
Technical Analysis
GLUEIMNM
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 11 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLCCX45.110.34
+0.76%
Fidelity Advisor Large Cap C
MRGBX43.220.22
+0.51%
MFS Core Equity B
TVLCX12.020.05
+0.43%
Touchstone Value C
NEQAX12.650.04
+0.32%
Neuberger Berman U.S. Equity Impact A
BMIAX7.260.01
+0.14%
BNY Mellon Income Stock A

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with EYPT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-1.29%
EYPT - GLUE
47%
Loosely correlated
-7.04%
IMNM - GLUE
44%
Loosely correlated
-0.23%
ATXS - GLUE
43%
Loosely correlated
N/A
CRSP - GLUE
43%
Loosely correlated
N/A
RXRX - GLUE
42%
Loosely correlated
-6.85%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-0.23%
IDYA - IMNM
61%
Loosely correlated
-4.13%
ARWR - IMNM
56%
Loosely correlated
+0.06%
BEAM - IMNM
55%
Loosely correlated
-1.98%
RXRX - IMNM
55%
Loosely correlated
-6.85%
SYRE - IMNM
54%
Loosely correlated
-4.99%
More